Medical, Surgical and Experimental Approaches to Acute Mesenteric Ischemia and Reperfusion.

Zoran Matkovic, Zoran Aleksic
{"title":"Medical, Surgical and Experimental Approaches to Acute Mesenteric Ischemia and Reperfusion.","authors":"Zoran Matkovic, Zoran Aleksic","doi":"10.5455/msm.2024.36.77-81","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute mesenteric ishemia(AMI) is a rare but very serious disease with high rate of mortality and morbidity. About 1-2% of all gastrointestinal disease is AMI. Mortality is about 60-80% and depends of time between starting of symptoms and establishing of diagnosis, type AMI, comorbidities. AMI is often in older population with coronary syndrom and atrial fibrilation. AMI may be occlusive(embolisatio arteriae mesentericae superior(AMS), or thrombosis of AMS, mesenterial vein thrombosis) and nonoclusive form(NOMI). NOMI is rising in critical ill patients in shock or sepsis. Pathophysiology of AMI is very complex and significant role in this proces has ischemia and also reperfusion. Reperfusion injury including oxidative stres, inflamation, infection. The best diagnostic approach is CT angiography but after high clinical suspicion on AMI. Patients have sudden, catastrophic abdominal pain, vomitus, bloody diarrhoea. Therapy is multidisciplinary-basic treatment(resuscitation with cristaloids, antibiotic, anticoagulans...), surgical treatment-resection necrotic segments of intestinum without anastomosis or endovascular treatment. In early phases conservative treatment is possible( vasodilatation, thrombolysis). In some countries there are Intestinal Stroke Centers (ISC) in which patients with AMI have better prognosis. Because of progressive nature of AMI( rapide worsening) rare are clinical study,but there are many experimental study on animal models. Most of experimental study investigate protective effects of some supstances on damage on intestinum and remote organs during ishemia and reperfusion.</p><p><strong>Objective: </strong>To present literature data of clinical and experimental study, describe experiments on animal models and mention supstances whit promising results in protective strategies during AMI.</p><p><strong>Methods: </strong>We analysed Pubmed by using mesh terms such as acute mesenteric ischemia, intestinal injury, reperfusion, experimental study, clinical and therapeutic approach. Results: Sudden abdominal pain resists on opioids analgetics, high rate of CRP, hyperlactatemia, increase of D dimer is enough for suspicion of AMI. Often is delayed in establishing of diagnosis of AMI. CT angiography has sensitivity of 94%. Pneumatosis is sign of necrosis of intestinal wall. Classical surgical approach is dominant, more than 70%,. Endovascular treatment became often last few years. Experimental studies investigate occlusion of AMS with atraumatic clamp, with schemia and reperfusion in different intervals Most animals models are on wistar male rats.</p><p><strong>Conclusion: </strong>AMI has still high rate of mortality. Better diagnostic and therapeutic principles (shorter interval between appearance of symptoms and starting of therapy, multidisciplinary approach, higher percent of endovascular procedures), could decrease mortality. Experimental studies on animal models may be succesfull in development of new clinical, conservative approaches in the early phases of AMI in the future.</p>","PeriodicalId":94128,"journal":{"name":"Materia socio-medica","volume":"36 1","pages":"77-81"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10999141/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Materia socio-medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/msm.2024.36.77-81","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute mesenteric ishemia(AMI) is a rare but very serious disease with high rate of mortality and morbidity. About 1-2% of all gastrointestinal disease is AMI. Mortality is about 60-80% and depends of time between starting of symptoms and establishing of diagnosis, type AMI, comorbidities. AMI is often in older population with coronary syndrom and atrial fibrilation. AMI may be occlusive(embolisatio arteriae mesentericae superior(AMS), or thrombosis of AMS, mesenterial vein thrombosis) and nonoclusive form(NOMI). NOMI is rising in critical ill patients in shock or sepsis. Pathophysiology of AMI is very complex and significant role in this proces has ischemia and also reperfusion. Reperfusion injury including oxidative stres, inflamation, infection. The best diagnostic approach is CT angiography but after high clinical suspicion on AMI. Patients have sudden, catastrophic abdominal pain, vomitus, bloody diarrhoea. Therapy is multidisciplinary-basic treatment(resuscitation with cristaloids, antibiotic, anticoagulans...), surgical treatment-resection necrotic segments of intestinum without anastomosis or endovascular treatment. In early phases conservative treatment is possible( vasodilatation, thrombolysis). In some countries there are Intestinal Stroke Centers (ISC) in which patients with AMI have better prognosis. Because of progressive nature of AMI( rapide worsening) rare are clinical study,but there are many experimental study on animal models. Most of experimental study investigate protective effects of some supstances on damage on intestinum and remote organs during ishemia and reperfusion.

Objective: To present literature data of clinical and experimental study, describe experiments on animal models and mention supstances whit promising results in protective strategies during AMI.

Methods: We analysed Pubmed by using mesh terms such as acute mesenteric ischemia, intestinal injury, reperfusion, experimental study, clinical and therapeutic approach. Results: Sudden abdominal pain resists on opioids analgetics, high rate of CRP, hyperlactatemia, increase of D dimer is enough for suspicion of AMI. Often is delayed in establishing of diagnosis of AMI. CT angiography has sensitivity of 94%. Pneumatosis is sign of necrosis of intestinal wall. Classical surgical approach is dominant, more than 70%,. Endovascular treatment became often last few years. Experimental studies investigate occlusion of AMS with atraumatic clamp, with schemia and reperfusion in different intervals Most animals models are on wistar male rats.

Conclusion: AMI has still high rate of mortality. Better diagnostic and therapeutic principles (shorter interval between appearance of symptoms and starting of therapy, multidisciplinary approach, higher percent of endovascular procedures), could decrease mortality. Experimental studies on animal models may be succesfull in development of new clinical, conservative approaches in the early phases of AMI in the future.

急性肠系膜缺血和再灌注的内科、外科和实验方法。
背景:急性肠系膜缺血(AMI)是一种罕见但非常严重的疾病,死亡率和发病率都很高。在所有胃肠道疾病中,约有 1-2% 是急性肠系膜缺血。死亡率约为 60-80%,取决于症状出现与确诊之间的时间间隔、AMI 的类型和合并症。急性心肌梗死通常发生在患有冠状动脉综合征和心房颤动的老年人群中。AMI可分为闭塞型(肠系膜上动脉栓塞(AMS)或AMS血栓形成、肠系膜静脉血栓形成)和非闭塞型(NOMI)。NOMI在休克或败血症的危重病人中发病率较高。急性心肌梗死的病理生理学非常复杂,缺血和再灌注在其中起着重要作用。再灌注损伤包括氧化损伤、炎症和感染。最好的诊断方法是 CT 血管造影,但要在临床上高度怀疑急性心肌梗死之后进行。患者会突发灾难性腹痛、呕吐、血性腹泻。治疗方法是多学科的--基础治疗(使用抗菌素、抗生素、抗凝血剂......进行复苏)、手术治疗--切除坏死的肠段,但不吻合或进行血管内治疗。早期可以采取保守治疗(血管扩张、溶栓)。一些国家设有肠道卒中中心(ISC),AMI 患者在这些中心的预后较好。由于急性心肌梗死具有进展性(急剧恶化),临床研究很少,但有许多动物模型实验研究。大多数实验研究探讨了某些物质在缺血和再灌注过程中对肠道和远处器官损伤的保护作用:介绍临床和实验研究的文献数据,描述动物模型实验,并提及在急性心肌梗死期间具有保护性策略的药物:方法:我们使用急性肠系膜缺血、肠道损伤、再灌注、实验研究、临床和治疗方法等关键词对 Pubmed 进行了分析。结果服用阿片类镇痛药后出现突发性腹痛、CRP升高、高乳酸血症、D二聚体升高足以让人怀疑是急性肠系膜缺血。急性心肌梗死的诊断往往被延迟。CT 血管造影的敏感性为 94%。气肿是肠壁坏死的标志。传统手术方法占主导地位,超过 70%。近几年,血管内治疗开始普及。大多数动物模型以雄性 Wistar 大鼠为对象:结论:急性心肌梗死的死亡率仍然很高。更好的诊断和治疗原则(缩短症状出现与开始治疗之间的时间间隔、多学科方法、提高血管内手术的比例)可以降低死亡率。对动物模型的实验研究可能会在未来成功开发出新的临床保守治疗急性心肌梗死早期阶段的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信